Severe Delayed Emergence Following a Narcolepsy Attack
This paper reports a rare case of a 70-year-old male with APOE ε4/ε4 homozygosity and Alzheimer's disease who experienced a severe 19-hour delayed emergence from remimazolam-based general anesthesia, attributed to an underlying narcolepsy-related hypersomnia episode.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a person undergoes general anesthesia, the goal is a controlled, reversible state of unconsciousness. Once the surgery is finished and the drugs are stopped, the body should wake up within a predictable window of time, usually less than an hour. This recovery depends on the liver and blood breaking down the medication and the brain clearing the chemical fog. However, sometimes the waking process stalls. This phenomenon, known as delayed emergence, can happen for many reasons: the patient might have received too much medication, their body might struggle to process the drugs due to liver or kidney issues, or there could be an undetected problem in the brain like a stroke. For doctors, a patient who does not wake up on schedule is a medical puzzle that requires careful investigation to ensure the patient is safe and to understand what went wrong.
In a recent report from Renmin Hospital of Wuhan University, anesthesiologists faced a particularly baffling case involving a seventy-year-old man. The patient underwent a standard laparoscopic surgery to remove part of his stomach. The anesthesia team used a modern drug called remimazolam, which is designed to wear off quickly, along with other standard agents. The surgery went smoothly, and the drugs were stopped. Ten minutes later, the patient began breathing on his own, but he did not wake up. After a specific antidote was given, he briefly opened his eyes and was taken off the breathing tube, only to fall back into a deep sleep within three minutes. Over the next nineteen hours, he remained unresponsive to commands, though he could still pull away from painful stimuli. His vital signs were stable, and his blood tests showed no major metabolic errors that would explain such a long coma.
The medical team first considered the most obvious culprit: an overdose of the anesthetic drugs. However, the amount of medication the patient received was well within safe limits, and his brain activity monitors showed he was not deeply sedated by the drugs. They also ruled out common metabolic causes like low blood sugar or oxygen issues, as these were corrected quickly without the patient waking up. A scan of the brain was not immediately possible due to staffing, but the patient's pupils reacted normally to light, and he eventually woke up with full strength and no signs of a stroke. The team also looked at the patient's genes, specifically searching for variations in the enzyme that breaks down remimazolam. While they found many genetic variations, none of them were the specific, known mutations that would completely stop the drug from being processed. This left the team with a patient who had taken a standard dose of a fast-acting drug, had no obvious organ failure, and yet remained asleep for nearly a full day.
The breakthrough came not from the operating room, but from a deeper look at the patient's personal history and a more comprehensive genetic analysis. The researchers discovered that the patient had a history of Alzheimer's disease, a condition that had not been fully documented in his preoperative records. He had been taking medications for this condition, which were stopped three weeks before the surgery. More importantly, a detailed genetic test revealed that the patient carried two copies of a specific gene variant, known as APOE ε4, which is a strong risk factor for Alzheimer's disease. While this gene is known to affect memory, it is also linked to sleep problems. The researchers found that this specific genetic makeup can alter how the brain regulates the switch between sleep and wakefulness, making it harder to wake up.
The team concluded that the patient's prolonged sleep was likely a rare combination of his underlying Alzheimer's-related brain changes and a sleep disorder that had gone undiagnosed. The stress of surgery and the anesthesia may have triggered a severe episode of hypersomnia, a condition where a person sleeps excessively. The fact that the patient woke up quickly after receiving flumazenil, a drug that reverses sedation, suggests his brain was capable of waking up but was stuck in a deep sleep state that the anesthesia had pushed over the edge. This case highlights that for some patients, particularly those with specific genetic markers for Alzheimer's, the brain's ability to recover from anesthesia can be significantly impaired by factors that are not immediately obvious. It suggests that doctors should be aware that a patient's genetic background and hidden sleep disorders can play a major role in how long it takes to wake up after surgery, turning a routine recovery into a complex medical event.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.